The Euro-Asian Joint Master programme in Medical Technology and Healthcare Business (EMMaH) is a 2-year (120 ECTS) course, taught in English and run by the University of Lille (France), Hamburg University of Applied Sciences (Germany), the Polytechnic Institute of Porto (Portugal), and Taipei Medical University (Taiwan). Supported by a multicultural and multidisciplinary team of 46 staff, EMMaH covers different fields, from biomedical technologies and clinical research to healthcare business. The fast-changing healthcare diagnostics sector, boosted by innovation and demographic evolutions, is confronted with transformation in the healthcare landscapes. EMMaH’s main outcome is to reduce the lack of human resources in the research and technology-based sector of health science and biomedical engineering by increasing employability over a wide spectrum of positions and responsibilities. In four editions designed for 85 students, the consortium would allocate 60 EMJM high-level scholarships to excellent students worldwide to study one semester on each EU campus and complete a master thesis with any of the 4 partners. Graduates are awarded a joint diploma co-signed by the EU partners, the MSc from TMU and digital graduation certificates. EMMaH includes 13 associated partners (companies: Air Liquide, apoQlar, Bayer, IQVIA, Siemens; research institutes: INSERM, NHRI, ITRI; networks: RACS, CONIF; and HEIs: IFSF Brazil, HES-SO and UExeter), which contribute to strengthen the employability and supervise student projects and master theses. Moreover, they co-organize job fairs and offer industry and hospital internships. EMMaH partners carry out the EMJM project through two work packages: Project management and coordination; Student selection and supervision; Curriculum implementation; Promotion; Impact, sustainability and dissemination of results. Each partner leads tasks and coordinates activities in its field of expertise, all co-create and co-develop a set of 25 outputs.